Coliprotec F4
Escherichia coli, type 08, strain K87 (live)
Table of contents
Overview
The marketing authorisation for Coliprotec F4 has been withdrawn at the request of the marketing authorisation holder.
Authorisation details
| Product details | |
|---|---|
| Name |
Coliprotec F4
|
| Agency product number |
EMEA/V/C/003797
|
| Active substance |
live non-pathogenic Escherichia coli O8:K87
|
| International non-proprietary name (INN) or common name |
Escherichia coli, type 08, strain K87 (live)
|
| Species |
Pigs
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI09AE03
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Prevtec Microbia GmbH
|
| Revision |
2
|
| Date of issue of marketing authorisation valid throughout the European Union |
16/03/2015
|
| Contact address |
Geyerspergerstrasse 27
80689 München Germany |
Product information
15/01/2020 Coliprotec F4 - EMEA/V/C/003797 - R/0005
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for suidae
-
Live bacterial vaccines
-
Pig
Therapeutic indication
For active immunisation of pigs against enterotoxigenic F4-positive Escherichia coli in order to:
- reduce the incidence of moderate to severe post-weaning Escherichia coli diarrhoea (PWD) in pigs;
- reduce the colonisation of the ileum and faecal shedding of enterotoxigenic F4-positive Escherichia coli from infected pigs.